Skip to content

Establishment and Application of Personliazed Therapeutic Effect Prediction and Drug Efficacy Evaluation System For Advanced Cancer

Establishment and Application of Personliazed Therapeutic Effect Prediction and Drug Efficacy Evaluation System For Advanced Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018453
Enrollment
Unknown
Registered
2018-09-19
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Cancer

Interventions

Case series:Case series

Sponsors

Shanghai International Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Pathological histological diagnosis of advanced cancer; 2. The patients could provide biopsy,fresh tumor tissue or pleuroperitoneal fluids samples; 3. Objective tumors that meet RECIST 1.1 criteria and can be evaluated by CT/MRI; 4. KPS score = 60, expected survival time = 3 months; Comprehensive assessment of patients who can tolerate chemotherapy and targeted therapy; 5. The patient voluntarily signed the informed consent form, with good compliance, willing active treatment and follow-up.

Exclusion criteria

Exclusion criteria: 1. Unplanned reoperation after surgery; 2. KPS score = 60 points or blood biochemical tests suggest that patients are not suitable for continuing chemotherapy or chemotherapy has been delayed; 3. Cannot or refuse to collect tumor samples, including tumor tissue blocks, or malignant pleural effusion and ascites; 4. Refused to receive treatment plans or follow-up plans.

Design outcomes

Primary

MeasureTime frame
Objective response rate;Progression-Free-Survival;Overall survival;Disease Control Rate;Five-year survival rate;Quality of life score;

Countries

China

Contacts

Public ContactGang Ding

Shanghai International Medical Center

13817360711@163.com+86 13817360711

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026